Lifestyle and Alzheimer’s Disease In Down Syndrome- Life Stressors Supplement
Lifestyle and Alzheimer’s Disease In Down Syndrome- Life Stressors Supplement
批准号:
10839520
负责人:
Sigan L Hartley
金额:
$10.52万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-09-15 至 2025-08-31
关键词:
Abeta synthesisAdministrative SupplementAdultAdverse eventAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer&aposs disease riskAlzheimer’s disease biomarkerAmyloid beta-42Amyloid beta-ProteinAreaAwardBasic ScienceBiological MarkersBrainCardiovascular DiseasesCessation of lifeChildhoodChromosome 21ClinicalCodeCognitionCognitiveComputer softwareDataDementiaDivorceDown SyndromeEnrollmentEquationExerciseFamily memberFundingFutureGoalsHeadHealthImageImpaired cognitionInflammationInflammatoryIntellectual functioning disabilityInterleukin-10Interleukin-6InterventionInvestigationLate Onset Alzheimer DiseaseLifeLife ExperienceLife StyleLongevityMeasuresMediatingMental DepressionModelingObesityOccupationsParentsParticipantPathologicPersonsPhenotypePhysical activityPlasmaPositron-Emission TomographyPovertyPreventionProtocols documentationResearchRiskRisk FactorsRoleSerum MarkersSleepSleep DisordersSocial PoliciesStressful EventStructureSymptomsTechniquesTestingTimeUnited States National Institutes of Healthabeta accumulationabuse neglectadverse childhood eventsbiological sexbiomarker performancecognitive functioncognitive performancecohortextracellularhigh rewardhigh riskinflammatory markerlifestyle factorsmodifiable lifestyle factorsnovelpreventresilience factorresponsesocial engagementsocial interventionssociodemographicsstressortau Proteinstau-1virtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
People with Down syndrome (DS) evidence an overproduction of amyloid-beta (Aβ), due to having three
copies of chromosome 21. With age, Aβ aggregates into extracellular brain plaques, which is a hallmark
feature of Alzheimer’s disease (AD); however, there is variability in the age at which this AD pathology begins
and how clinical AD symptomology unfolds in DS. Stressful life experiences, both in childhood and in
adulthood, are associated with aging-related cognitive decline and risk of sporadic late onset AD outside of DS.
Stressful life experiences may exacerbate AD pathology and/or its effects on cognition through inflammation,
and/or by contributing to conditions (e.g., obesity, cardiovascular disease, depression, sleep disorders) that are
known risk factors for AD.
The goal of the Administrative Supplement, “Life Stressors and Alzheimer’s Disease in Down syndrome,” is to
expand on the R01AG70028 “Lifestyle Risk and Resiliency Factors and Alzheimer’s Disease in Down
syndrome” project to examine the effect of adverse childhood events (e.g., parent divorce, abuse/neglect,
poverty) and recent life stressors (e.g., job termination, new staff, death of family member) on the timing of AD
pathology and symptomology in people with Down syndrome. Specifically, this supplement will: 1) include a
new measure into the Lifestyle R01 protocol to capture adverse childhood experiences (ACEs); 2) use a new
coding technique to capture stressful life events in adulthood; and 3) conduct new analyses to determine the
association between stressful childhood and adult life experiences and AD imaging and biofluid biomarkers
and cognitive impairments.
The parent R01 follows 180 adults with DS who are co-enrolled in the NIH-funded Alzheimer’s Biomarker
Consortium in DS (ABC-DS), in which AD biomarkers (e.g., PET Aβ, and tau, CSF Aβ42, and plasma p-tau
217), cognitive functioning, and dementia status are collected. The parent Lifestyle R01 collects three time
points of data, aligning with ABC-DS cycles, and focuses on four modifiable lifestyle factors – physical activity,
sleep, cognitive stimulation, and social engagement. The “Life Stressors and Alzheimer’s Disease in Down
syndrome” Administrative Supplement will build on these aims by generating novel and significant information
on the effect of life stressors on AD in DS that can drive social policy and interventions in the future.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lifestyle and Alzheimer's Disease In Down Syndrome
-
批准号:10098587
-
项目类别:
-
资助金额:$79.44万
-
财政年份:2020
-
负责人:Sigan L Hartley
-
依托单位:
Lifestyle and Alzheimer's Disease In Down Syndrome
-
批准号:10263355
-
项目类别:
-
资助金额:$73.64万
-
财政年份:2020
-
负责人:Sigan L Hartley
-
依托单位:
Lifestyle and Alzheimer's Disease In Down Syndrome
-
批准号:10474454
-
项目类别:
-
资助金额:$69.37万
-
财政年份:2020
-
负责人:Sigan L Hartley
-
依托单位:
Lifestyle Risk and Resiliency Factors and Alzheimer’s Disease in Down syndrome
-
批准号:10669953
-
项目类别:
-
资助金额:$23.47万
-
财政年份:2020
-
负责人:Sigan L Hartley
-
依托单位:
Lifestyle and Alzheimer's Disease In Down Syndrome
-
批准号:10696137
-
项目类别:
-
资助金额:$67.61万
-
财政年份:2020
-
负责人:Sigan L Hartley
-
依托单位:
Family Outcomes in Autism Spectrum Disorders
-
批准号:9223757
-
项目类别:
-
资助金额:$39.93万
-
财政年份:2013
-
负责人:Sigan L Hartley
-
依托单位:
Family Outcomes in Autism Spectrum Disorders
-
批准号:8524248
-
项目类别:
-
资助金额:$52.73万
-
财政年份:2013
-
负责人:Sigan L Hartley
-
依托单位:
Family Outcomes in Autism Spectrum Disorders
-
批准号:8666667
-
项目类别:
-
资助金额:$39.93万
-
财政年份:2013
-
负责人:Sigan L Hartley
-
依托单位:
Family Outcomes in Autism Spectrum Disorders
-
批准号:8806603
-
项目类别:
-
资助金额:$39.93万
-
财政年份:2013
-
负责人:Sigan L Hartley
-
依托单位:
Post-Doctoral Training in Intellectual and Developmental Disabilities Research
-
批准号:10395978
-
项目类别:
-
资助金额:$29.1万
-
财政年份:1995
-
负责人:Sigan L Hartley
-
依托单位:
Post-Doctoral Training in Intellectual and Developmental Disabilities Research
-
批准号:9274040
-
项目类别:
-
资助金额:$23.49万
-
财政年份:1995
-
负责人:Sigan L Hartley
-
依托单位:
Post-Doctoral Training in Intellectual and Developmental Disabilities Research
-
批准号:10614461
-
项目类别:
-
资助金额:$30.42万
-
财政年份:1995
-
负责人:Sigan L Hartley
-
依托单位:
海外基金